InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Comments on India’s draft biotech patent guidelines posted

Peter Leung, Hong Kong


The India Patent Office has released public feedback to its draft guidelines for the examination of biotechnology patents

The guidelines were released on December 11 2013 with a public comment period until January 11. The Patent Office received comments from Indian biotechnology firms, patent law firms, and groups such as the Organisation of Pharmaceuticals Producers of India (OPPO), the Biotechnology Industry Organization (BIO) and even the Japan Intellectual Property...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Our weekly IP round-up includes Panasonic, Taylor Swift, Motorola, Intellectual Ventures, AT&T http://t.co/bpGxNLKGq7 http://t.co/YQR35RbRve

Mar 28 2015 04:25 ·  reply ·  retweet ·  favourite
ManagingIP profile

Judge Smith on why big numbers is not proof of PTAB success, and clarification of his "death squadding" quote ($) http://t.co/i7ZoWCKsfg

Mar 27 2015 05:50 ·  reply ·  retweet ·  favourite
ManagingIP profile

.@uspto Director Michelle Lee outlines "quick fixes" to #PTAB page limits http://t.co/611famdq4n ($/trial) http://t.co/F5Y8GqG8Xn

Mar 27 2015 05:22 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


AIPLA Daily Report 2014

Read this year's AIPLA Daily Report - published daily by Managing IP direct from the AIPLA Annual Meeting in Washington DC


null null null

April 2015

Zynga’s IP game

The gaming company’s IP lawyer Renee Lawson tells Emma Barraclough about the move from partner to start-up, why the company listens to its lawyers, and the ups and downs of cross-border litigation



Most read articles

Supplements